Sign In / Join

close

Clinical Trials

Our Clinical Trials articles highlight top clinical trials, their results, and how patients can participate in them.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

How Effective is R-CHOP vs BR Treatment for Follicular Lymphoma?

December 03, 2024

Read the latest findings from Dr. Baron and her team at Huntsman Cancer Institute on the efficacy of BR versus R-CHOP in treating follicular lymphoma.

DLBCL Clinical Trials: Promising Phase 1 Results of Golcadomide + R-CHOP

November 19, 2024

Learn how golcadomide in combination with R-CHOP helped DLBCL patients in a phase 1 clinical trial.

Recruiting Trials for New Therapy Regimen for AML Patients

October 29, 2024

Explore iadademstat for AML treatment in Oryzon Genomics' latest clinical trials with promising results.

RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

October 22, 2024

What is RVU120, a new medicine in clinical trials, and how may it help reduce signs/symptoms of AML, MDS, and myelofibrosis?

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results

October 14, 2024

Learn about anitocabtagene autoleucel, a new CAR-T treatment for relapsed myeloma patients, showing promising results in Phase I trials.

CAR-T Therapy Trial for Relapsed/Refractory Acute Myeloid Leukemia

October 09, 2024

Explore the AMpLify trial testing CRISPR-edited CAR-T therapy CB-012 for relapsed/refractory AML, now recruiting patients for Phase 1.

New Clinical Trial with Armored CAR T-cells

October 01, 2024

Understanding CAR T-Cell Therapy and the Armored CAR T-Cell Trial

What are Clinical Trials, and How May They Help Me?

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.

Off-the-Shelf CAR NK Cell Therapy for Relapsed/Refractory AML and MDS

September 16, 2024

Promising new off-the-shelf CAR NK cell therapy, SENTI-202, offers hope for relapsed/refractory AML & MDS. Learn about eligibility and trial locations.

BTK Degrader for R/R CLL/SLL Receives FDA Fast Track Designation

September 06, 2024

Learn how BTK degrader BGB-16673 can aid in managing CLL/SLL if you've previously taken BTK inhibitors and venetoclax.

Trending Articles

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Tax ID 45-5354811

Clinical Trials

Recent Articles

How Effective is R-CHOP vs BR Treatment for Follicular Lymphoma?

DLBCL Clinical Trials: Promising Phase 1 Results of Golcadomide + R-CHOP

Recruiting Trials for New Therapy Regimen for AML Patients

RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results

CAR-T Therapy Trial for Relapsed/Refractory Acute Myeloid Leukemia

New Clinical Trial with Armored CAR T-cells

What are Clinical Trials, and How May They Help Me?

Off-the-Shelf CAR NK Cell Therapy for Relapsed/Refractory AML and MDS

BTK Degrader for R/R CLL/SLL Receives FDA Fast Track Designation

Trending Articles

What is Pancytopenia? Symptoms, Causes, & Treatments

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

The Future of Blood Cancer: Advances in Detection, Treatment, and Research

What are Clinical Trials, and How May They Help Me?

What Research is Being Discussed for DLBCL at ASH 2024?

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info

Clinical Trials

Recent Articles

How Effective is R-CHOP vs BR Treatment for Follicular Lymphoma?

DLBCL Clinical Trials: Promising Phase 1 Results of Golcadomide + R-CHOP

Recruiting Trials for New Therapy Regimen for AML Patients

RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results

CAR-T Therapy Trial for Relapsed/Refractory Acute Myeloid Leukemia

New Clinical Trial with Armored CAR T-cells

What are Clinical Trials, and How May They Help Me?

Off-the-Shelf CAR NK Cell Therapy for Relapsed/Refractory AML and MDS

BTK Degrader for R/R CLL/SLL Receives FDA Fast Track Designation

Trending Articles

What is Pancytopenia? Symptoms, Causes, & Treatments

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

The Future of Blood Cancer: Advances in Detection, Treatment, and Research

What are Clinical Trials, and How May They Help Me?

What Research is Being Discussed for DLBCL at ASH 2024?

Get the latest thought leadership on your Blood Cancer delivered straight to your inbox

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info